Long-term investment ideas to double your money? This stock can do it for you and other shares to buy now
Stocks to buy: Stocks to buy: Tata Consultancy Services (TCS), Gabriel India, Thermax and GlaxoSmithKline Pharma are among top four stocks that may give returns of up to 21 per cent
Stocks to buy: Tata Consultancy Services (TCS), Gabriel India, Thermax and GlaxoSmithKline Pharma are among top four stocks that may give returns of up to 21 per cent, as per domestic brokerages such as Motilal Oswal, Geojit and Institutional Research. One may consider the brokerage recommendations for positive yield. (Disclaimer: The advice given here to invest in stocks is given by the brokerage house. These are not the views of Zee Business. Before investing, consult your advisor.)
Gabriel India
Tata Consultancy Services (TCS)
GlaxoSmithKline Pharma
GlaxoSmithKline Pharma Share Price Target 2023: Motilal Oswal has a 'neutral' rating on the pharma major for a target price of Rs 1,300 apiece, which implies a potential upside of Rs Rs 40 per share or 3 per cent, from the current price level of Rs 1,260. GlaxoSmithKline Pharma stock price last closed at Rs 1,259.95 at NSE. Pic: Pixabay
Thermax
Thermax Share Price Target 2023: Institutional Research has an 'add' rating on the Indian multinational engineering conglomerate for a target price of Rs 2,433 apiece. The stock currently trades at Rs 2,254. Investors can earn a return of Rs 179 per share or 7.9 per cent. Thermax stock price last closed at Rs 2,253.65 at NSE. Pic: Pixabay